- Home
- ZD vs BLFS Comparison
ZD vs BLFS Comparison
Compare ZD & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZD
- BLFS
- Stock Information
- Founded
- ZD 1995
- BLFS 1987
- Country
- ZD United States
- BLFS United States
- Employees
- ZD N/A
- BLFS N/A
- Industry
- ZD Advertising
- BLFS Medical/Dental Instruments
- Sector
- ZD Consumer Discretionary
- BLFS Health Care
- Exchange
- ZD Nasdaq
- BLFS Nasdaq
- Market Cap
- ZD 1.6B
- BLFS 1.3B
- IPO Year
- ZD 1999
- BLFS 1989
- Fundamental
- Price
- ZD $30.04
- BLFS $24.26
- Analyst Decision
- ZD Hold
- BLFS Strong Buy
- Analyst Count
- ZD 5
- BLFS 7
- Target Price
- ZD $37.00
- BLFS $30.86
- AVG Volume (30 Days)
- ZD 631.4K
- BLFS 317.6K
- Earning Date
- ZD 11-06-2025
- BLFS 11-06-2025
- Dividend Yield
- ZD N/A
- BLFS N/A
- EPS Growth
- ZD 92.61
- BLFS N/A
- EPS
- ZD 2.65
- BLFS N/A
- Revenue
- ZD $1,457,379,000.00
- BLFS $100,144,000.00
- Revenue This Year
- ZD $8.37
- BLFS $25.65
- Revenue Next Year
- ZD $3.95
- BLFS $14.81
- P/E Ratio
- ZD $11.79
- BLFS N/A
- Revenue Growth
- ZD 5.70
- BLFS 87.53
- 52 Week Low
- ZD $28.55
- BLFS $19.10
- 52 Week High
- ZD $60.62
- BLFS $29.62
- Technical
- Relative Strength Index (RSI)
- ZD 26.83
- BLFS 33.58
- Support Level
- ZD $30.28
- BLFS $25.49
- Resistance Level
- ZD $34.05
- BLFS $28.21
- Average True Range (ATR)
- ZD 1.48
- BLFS 1.01
- MACD
- ZD -0.31
- BLFS -0.39
- Stochastic Oscillator
- ZD 8.91
- BLFS 7.78
About ZD Ziff Davis Inc.
Ziff Davis Inc is a focused digital media and internet company whose portfolio includes brands in technology, entertainment, shopping, health, cybersecurity, and martech. It has two reportable segments: Digital Media and Cybersecurity and Martech. The company's brands include Mashable, Ookla, Offers.com, IGN, and VPN among others. The majority of revenue is generated from Digital Media.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.